SDGR NASDAQ
Credit Risk of going bust: lower than 56% of companies Debt: 5.6% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.18 (down 99.3%), Schrödinger, Inc. would be worth roughly what it owes.
Total debt $108.0M against a stock market value of $1.83B.
Distance to default 5.71 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $54.0M (short-term plus half of long-term), stock volatility 61.5%; Altman Z'' 0.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
New York, NY 10036
US
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Akinsanya Karen | S-Sale | 10,000 | $28.00 | 2026-09-17 |
| Akinsanya Karen | S-Sale | 21,599 | $30.00 | 2026-09-17 |
| Jain Rachit | S-Sale | 875 | $15.60 | 2026-07-16 |
| Friesner Richard | G-Gift | 679,373 | — | 2026-06-26 |
| Friesner Richard | G-Gift | 679,373 | — | 2026-06-26 |